Efficacy Of Intralesional Ciprofloxacin In Cutaneous Leishmaniasis As Compared To Intralesional Meglumine Antimoniate
Journal of Rawalpindi Medical College · 30.06.2026 · 30 (2) · 366-371
DOI: 10.37939/jrmc.v30i2.3160 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Rawalpindi Medical College, online erschienen am 30.06.2026. Verfasst von Humna Zafar und 5 weiteren Autor:innen. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).
Abstract (Originalsprache)
Objective
Cutaneous leishmaniasis (CL), a neglected tropical disease, poses a significant therapeutic challenge in endemic regions. Although intralesional meglumine antimoniate (MA) remains a standard treatment, its drawbacks necessitate the exploration of safer and, cheaper alternatives. This within-patient comparative study aimed to evaluate the efficacy of intralesional 0.2% ciprofloxacin compared with that of intralesional meglumine antimoniate in the treatment of CL.
Methods
A six-month comparative study was conducted at the Dermatology Department of a tertiary care hospital in, Malir Cantt, Karachi. A total of 128 patients with confirmed cutaneous leishmaniasis were enrolled. Only patients presenting with at least two lesions located on the contralateral sides of the body were included. Right-sided lesions were treated with intralesional 0.2% ciprofloxacin (Group A), whereas while left-sided lesions received intralesional meglumine antimoniate (Group B). Injections were administered every fifth day until re-epithelialization commenced. The primary outcome was the proportion of lesions achieving a complete clinical response (>75% reduction in size without induration) at eight weeks post-treatment initiation.
Results
The mean age of the participants was 30.6 ± 7.1 years, with a male predominance (78.9%). The complete response rate was 88.3% (113/128) in the ciprofloxacin group and 91.4% (117/128) in the meglumine antimoniate group. The difference in efficacy was not statistically significant (p-value = 0.486). Stratification by demographic and clinical variables revealed no significant differences in response rates across any subgroup.
Conclusion
Intralesional ciprofloxacin demonstrated comparable efficacy to that of intralesional meglumine antimoniate in the treatment of cutaneous leishmaniasis. Given its lower cost and favorable safety profile, ciprofloxacin may be a viable alternative therapeutic option, particularly in resource-constrained settings. Keywords: Cutaneous Leishmaniasis; Ciprofloxacin; Meglumine Antimoniate; Injections, Intralesional; Treatment Outcome
Zitieren
APA
Zafar, H., Kausar, S., Mazhar, H., Nawaz, F. U. H., Rehman, N., & Yasmin, G. (2026). Efficacy Of Intralesional Ciprofloxacin In Cutaneous Leishmaniasis As Compared To Intralesional Meglumine Antimoniate. Journal of Rawalpindi Medical College, 30(2), 366-371. https://doi.org/10.37939/jrmc.v30i2.3160
Vancouver
Zafar H, Kausar S, Mazhar H, Nawaz FUH, Rehman N, Yasmin G. Efficacy Of Intralesional Ciprofloxacin In Cutaneous Leishmaniasis As Compared To Intralesional Meglumine Antimoniate. Journal of Rawalpindi Medical College. 2026;30(2):366-371. doi:10.37939/jrmc.v30i2.3160
BibTeX
@article{Zafar2026,
author = {Zafar, Humna and Kausar, Sameena and Mazhar, Hina and Nawaz, Faiz ul Hassan and Rehman, Naila and Yasmin, Ghazala},
title = {Efficacy Of Intralesional Ciprofloxacin In Cutaneous Leishmaniasis As Compared To Intralesional Meglumine Antimoniate},
journal = {Journal of Rawalpindi Medical College},
year = {2026},
volume = {30},
number = {2},
pages = {366--371},
doi = {10.37939/jrmc.v30i2.3160}
}
EUVIMED